Anovulation Clinical Trial
Official title:
Ultrasound Assessment of Uterine and Endometrium Volume in Women With PCOS and HPOD
Group II causes of anovulation according to the World Health Organization include polycystic ovary syndrome (PCOS) and the less common dysfunction of the hypothalamic-pituitary-ovarian axis (HPOD). Assessment of ovarian volume, number and morphology of ovarian follicles is essential in the diagnosis of menstrual disorders, including PCOS and HPOD. However, the uterus is a target organ for steroid hormones, and the assessment of uterine size and endometrial morphology may also be of clinical importance. While ultrasonographic features of the ovaries in PCOS have been described and constitute one of the diagnostic criteria for the syndrome (Rotterdam criteria), there is little data on uterine volume in women with PCOS and HPOD. The aim is to compare ultrasound i) uterine volume and ii) endometrial volume among women with PCOS and women with HPOD.
Group II causes of anovulation according to the World Health Organization include polycystic ovary syndrome (PCOS) and the less common dysfunction of the hypothalamic-pituitary-ovarian axis (HPOD). The exact etiology of both entities is unknown. The diagnosis of PCOS requires meeting the Rotterdam criteria. HPOD, in turn, is considered a functional disorder of the axis, related to lifestyle factors, and the diagnosis is made after excluding identifiable causes of ovulation disorders. Assessment of ovarian volume, number and morphology of ovarian follicles is essential in the diagnosis of menstrual disorders, including PCOS and HPOD. However, the uterus is a target organ for steroid hormones, and the assessment of uterine size and endometrial morphology may also be of clinical importance. The dimensions and volume of the uterus and endometrium may influence the clinical pregnancy rate in women undergoing assisted reproductive technologies. Both too small and too large sizes and volumes of the uterus may reduce the rate of clinical pregnancies. Too small dimensions may result from hypoestrogenism, while excessive size may be the result of estrogen-progesterone imbalance accompanying PCOS, increased uterine vascularity, as well as estrogen-dependent changes in the uterine myometrium, such as adenomyosis. Similarly, too "thin" endometrium and too thick (cystic) endometrium may reduce the receptivity of the endometrium. While ultrasonographic features of the ovaries in PCOS have been described and constitute one of the diagnostic criteria for the syndrome (Rotterdam criteria), there is little data on uterine volume in women with PCOS and HPOD. The aim is to compare ultrasound uterine volume and endometrial volume among women with PCOS and women with HPOD. The volume of the uterus will be determined according to the formula: V = (π/6) × length × width × height (in cm and given in ml). The volume of the endometrium will also be measured according to a similar formula. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01653743 -
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
|
Phase 3 | |
| Completed |
NCT00327366 -
Effect of Bright Light on Sex Hormones and Ovulation in Humans
|
N/A | |
| Not yet recruiting |
NCT02551367 -
Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )
|
Phase 2 | |
| Completed |
NCT01923194 -
Evaluation of Efficacy and Safety of Highly Purified Urofollitropin for Ovulation Induction in Chinese Females
|
Phase 3 | |
| Completed |
NCT01008319 -
Traditional Clomiphene Citrate Administration vs. Stair-step Approach
|
Phase 3 | |
| Completed |
NCT00239603 -
Efficacy Study of the OV-Watch™ Personal Fertility Monitor for Women Using Clomiphene Citrate.
|
Phase 4 | |
| Recruiting |
NCT02309047 -
The Cycle Disturbances, OLigomenorrhea and Amenorrhea (COLA) Study & Biobank
|
||
| Completed |
NCT03252223 -
Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
|
Phase 4 | |
| Completed |
NCT00492882 -
Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome
|
Phase 4 | |
| Completed |
NCT02335879 -
Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
|
Phase 3 | |
| Completed |
NCT00471523 -
Treatment of Anovulatory Infertility in PCOS Patients
|
Phase 4 | |
| Completed |
NCT02703649 -
Administration of Single High Dose Letrozole for Ovulation Induction
|
Phase 4 | |
| Completed |
NCT00213148 -
Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction
|
Phase 2 | |
| Completed |
NCT03018314 -
Serum Kisspeptin Levels in Infertile Women
|
N/A | |
| Completed |
NCT02710981 -
Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium
|
N/A | |
| Recruiting |
NCT02186782 -
Concomitant CC and E2 Versus CC Alone in Ovulation Induction
|
Phase 4 | |
| Not yet recruiting |
NCT00665171 -
Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome
|
N/A | |
| Withdrawn |
NCT03155828 -
Using CPAP to Improve Menstruation in Women With Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
|
||
| Withdrawn |
NCT00453219 -
FHA: Characterization of Metabolic Status, Brain Circuitry, and Stress-Reactivity
|
N/A | |
| Completed |
NCT00920634 -
Protocol for Drug Use Investigation of Follistim Injection (Study P06132)(COMPLETED)
|